CompletedNot Applicable

Evaluation of Soluble Fibrin in Thrombosis Exclusion

France863 participantsStarted 2015-09

Plain-language summary

The purpose of the study is to evaluate the performances of Soluble Fibrin assay for exclusion of Pulmonary Embolism and Deep Venous Thrombosis. Secondary objectives are to determine the threshold value from the ROC curves, the possible interest in the positive diagnosis of Venous Thromboembolism (VTE), and to verify the absence of influence of age on the SF results.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with non-opposition to participate in the evaluation, * outpatients from Emergency or Internal Medicine Units, * clinically suspected of PE or DVT. Exclusion Criteria: * patients under 18 years old, * patients with opposition to participate in the evaluation, * patients with contraindication to iodinated contrast media.

What they're measuring

Performances of the Soluble Fibrin Assay for the exclusion of PE and DVT

Timeframe: 24 Months

Trial details

NCT IDNCT02523937

SponsorDiagnostica Stago R&D

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2018-05

View on ClinicalTrials.gov More Pulmonary Embolism (PE) trials